Kinsale Capital Group stock hits 12-month low after analyst downgrade

Jefferies Financial Group downgrades KNSL to 'underperform' with $312 price target

Mar. 19, 2026 at 2:18pm

Got story updates? Submit your updates here. ›

Shares of Kinsale Capital Group, Inc. (NYSE:KNSL) reached a new 52-week low on Thursday after Jefferies Financial Group downgraded the stock from 'hold' to 'underperform' and set a $312 price target. The specialty insurance company's stock traded as low as $331.79 on the day.

Why it matters

Kinsale Capital Group is a fast-growing specialty insurance provider focused on complex and underserved risks. The analyst downgrade and new 52-week low price point raise concerns about the company's near-term outlook and valuation, which could impact investor confidence and the stock's performance.

The details

Jefferies Financial Group cited concerns about Kinsale Capital Group's growth prospects and valuation in its downgrade. The firm previously had a 'hold' rating on the stock with a $415 price target. Other analysts have a more mixed view, with four 'buy' ratings, six 'hold' ratings, and two 'sell' ratings on the stock.

  • Kinsale Capital Group stock reached a new 52-week low of $331.79 on Thursday, March 19, 2026.
  • Jefferies Financial Group downgraded the stock from 'hold' to 'underperform' on Thursday, March 19, 2026.

The players

Kinsale Capital Group, Inc.

A specialty property and casualty insurance company headquartered in Richmond, Virginia, that focuses on underwriting complex and underserved risks across the United States.

Jefferies Financial Group

A global investment banking firm that provides a full range of investment banking, advisory, sales and trading, research and asset management services.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident

The takeaway

The Kinsale Capital Group downgrade highlights the volatility and uncertainty in the specialty insurance market, as analysts weigh the company's growth potential against valuation concerns. Investors will be closely watching Kinsale's performance and any further analyst actions in the coming months.